SOHO State of the Art Updates and Next Questions: Harnessing Apoptosis in AML
Open Access
- 3 September 2021
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22 (3), 133-139
- https://doi.org/10.1016/j.clml.2021.08.015
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complexLeukemia, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Human Acute Myelogenous Leukemia Stem Cells Revisited: There's More Than Meets the EyeCancer Cell, 2011
- APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cellsEuropean Journal of Haematology, 2010
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaCancer Cell, 2006
- Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family membersCancer Cell, 2006
- Apoptosis in the development and treatment of cancerCarcinogenesis: Integrative Cancer Research, 2004
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994